[Consequences of Gout and Hyperuricemia]
Insights
Hyperuricemia (HU) and gout are linked to cardiovascular disease (CVD) due to shared causes like obesity and metabolic syndrome. Gout is treatable with urate-lowering therapy (ULT), potentially improving associated conditions.
Area of Science:
- Cardiovascular Science
- Nephrology
- Neurology
Background:
- Hyperuricemia (HU) and gout exhibit strong associations with cardiovascular disease (CVD), likely stemming from shared underlying etiologies.
- HU is causally linked to metabolic syndrome, obesity, and can contribute to or result from impaired kidney function.
- Observational studies suggest potential protective effects of HU against neurodegenerative conditions like Alzheimer's and Parkinson's disease.
Purpose of the Study:
- To explore the complex relationship between hyperuricemia, gout, and associated comorbidities.
- To discuss the role of urate-lowering therapy (ULT) in managing gout and its impact on related health issues.
- To address existing controversies regarding HU's influence on cardiovascular and neurodegenerative diseases.
Main Methods:
- Review of existing literature on hyperuricemia, gout, and their associations with cardiovascular and neurodegenerative diseases.
- Analysis of observational data and ongoing randomized controlled trials (RCTs) concerning urate and ULT.
- Discussion of the etiological links between HU, metabolic syndrome, obesity, and kidney function.
Main Results:
- The association between HU/gout and CVD is likely multifactorial, involving shared risk factors rather than direct causality.
- HU and gout can negatively impact kidney function, while also being influenced by renal health.
- Emerging evidence suggests a potential neuroprotective role for HU in certain neurodegenerative diseases, though further research is needed.
- Ongoing RCTs are crucial for clarifying the causal relationships and therapeutic potential of ULT.
Conclusions:
- Gout is a curable condition with urate-lowering therapy (ULT).
- Adequate ULT may offer benefits for comorbidities associated with gout and hyperuricemia.
- Further research, including RCTs, is essential to fully understand the multifaceted roles of urate in health and disease.
Abstract:
Hyperuricemia (HU) and gout are strongly associated with CVD, associations that are most likely due to shared etiologies rather than causality. HU is for example causally related to the metabolic syndrome and in particular to obesity. Gout and HU can both be caused by and lead to decreased kidney function. On the other hand, there are observational data suggesting that HU may protect against neurodegenerative diseases such as Alzheimer and Parkinson's disease. Ongoing RCTs with urate and urate lowering therapy (ULT) will help to resolve some of these controversies. Nevertheless, gout is a "curable disease" by ULT, a treatment which in adequate doses may also have positive effect on several associated co-morbidities.
More Related Videos
11:47Using 2-Photon Microscopy to Quantify the Effects of Chronic Unilateral Ureteral Obstruction on Glomerular Processes
Published on: March 4, 2022
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
Related Concept Videos
Antihypertensive Drugs: Action of Diuretics
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
Chronic Kidney Disease II: Clinical Manifestations
Urinary Tract Calculi IV: Nutrition Therapy and Prevention
Physiology of Urine Formation
Glomerular Filtration
The first stage in urine formation is glomerular filtration. Each kidney contains approximately 1 million nephrons, the functional units of filtration, with a...
Nephrotic Syndrome I : Introduction
![Quantitative SERS Detection of Uric Acid via Formation of Precise Plasmonic Nanojunctions within Aggregates of Gold Nanoparticles and Cucurbit[n]uril](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F61682.jpg&w=3840&q=50)